Literature DB >> 16500583

Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction.

Daniel R Wagner1, Charles Delagardelle, Isabelle Ernens, Didier Rouy, Michel Vaillant, Jean Beissel.   

Abstract

BACKGROUND: Matrix metalloproteinases (MMPs) have been associated with the development of left ventricular remodeling after myocardial infarction (MI). We sought to determine whether peripheral levels of MMPs can be used as a risk marker for the development of congestive heart failure (CHF) after acute MI. METHODS AND
RESULTS: Plasma levels of MMP-2, MMP-9, C-reactive protein (hs-CRP), tumor necrosis factor-alpha (TNF-alpha), and pro-brain natriuretic peptide (pro-BNP) were measured in 109 consecutive patients with acute MI treated with primary mechanical reperfusion. Echocardiographic assessment of left ventricular wall motion index was performed during admission. Patients were followed for the development of CHF. Left ventricular function and volumes were determined after 2 years with radionuclide ventriculography. During 2-year follow-up, 15 patients developed congestive heart failure (CHF). Using multivariate analysis, MMP-9 levels were the only circulating factor predictive of late onset CHF. Patients who had high MMP-9 levels had a significant risk of late onset CHF (OR of 6.5, P < or = .006) and left ventricular remodeling (DeltaEF = -9%, P = .03, and Deltaend-diastolic volume = +13 mL, P = .03). MMP-2, TNF-alpha, hs-CRP, creatine kinase, and pro-BNP were not predictive of late onset CHF.
CONCLUSION: MMP-9 levels may hold prognostic significance in MI patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16500583     DOI: 10.1016/j.cardfail.2005.08.002

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  38 in total

Review 1.  Challenges and standards in reporting diagnostic and prognostic biomarker studies.

Authors:  Francisco Azuaje; Yvan Devaux; Daniel Wagner
Journal:  Clin Transl Sci       Date:  2009-04       Impact factor: 4.689

2.  Application of Hybrid Matrix Metalloproteinase-Targeted and Dynamic 201Tl Single-Photon Emission Computed Tomography/Computed Tomography Imaging for Evaluation of Early Post-Myocardial Infarction Remodeling.

Authors:  Stephanie L Thorn; Shayne C Barlow; Attila Feher; Mitchel R Stacy; Heather Doviak; Julia Jacobs; Kia Zellars; Jennifer M Renaud; Ran Klein; Robert A deKemp; Aarif Y Khakoo; TaeWeon Lee; Francis G Spinale; Albert J Sinusas
Journal:  Circ Cardiovasc Imaging       Date:  2019-11-11       Impact factor: 7.792

3.  Association of polymorphisms of zinc metalloproteinases with clinical response to stem cell therapy.

Authors:  R Panovsky; A Vasku; J Meluzin; M Kaminek; J Mayer; S Janousek; V Kincl; L Groch; M Navratil
Journal:  Herz       Date:  2010-08       Impact factor: 1.443

Review 4.  Role of various proteases in cardiac remodeling and progression of heart failure.

Authors:  Alison L Müller; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 5.  Changes in the myocardial interstitium and contribution to the progression of heart failure.

Authors:  Shaina R Eckhouse; Francis G Spinale
Journal:  Heart Fail Clin       Date:  2012-01       Impact factor: 3.179

Review 6.  Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling.

Authors:  Merry L Lindsey
Journal:  Nat Rev Cardiol       Date:  2018-08       Impact factor: 32.419

7.  Coordinated modular functionality and prognostic potential of a heart failure biomarker-driven interaction network.

Authors:  Francisco Azuaje; Yvan Devaux; Daniel R Wagner
Journal:  BMC Syst Biol       Date:  2010-05-12

Review 8.  Translating Koch's postulates to identify matrix metalloproteinase roles in postmyocardial infarction remodeling: cardiac metalloproteinase actions (CarMA) postulates.

Authors:  Rugmani Padmanabhan Iyer; Lisandra E de Castro Brás; Yu-Fang Jin; Merry L Lindsey
Journal:  Circ Res       Date:  2014-02-28       Impact factor: 17.367

9.  Absence of regeneration in the MRL/MpJ mouse heart following infarction or cryoinjury.

Authors:  Thomas E Robey; Charles E Murry
Journal:  Cardiovasc Pathol       Date:  2007-03-21       Impact factor: 2.185

Review 10.  MMP-9 signaling in the left ventricle following myocardial infarction.

Authors:  Rugmani Padmanabhan Iyer; Mira Jung; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-20       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.